Advanced Characterization Approaches for Quality Control of LNP Formulation
Time: 12:00 pm
day: Day Two
Details:
- What considerations should be taken into account when formulating LNPs for various types of therapeutic payloads, such as mRNA, siRNA, or small molecules?
- Addressing concerns related to immune response, biodistribution, and targeted delivery
- What strategies can be employed to improve the encapsulation of mRNA molecules within LNPs?
